Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

HSRx 351

Next Previous
Drug Profile

HSRx 351

Alternative Names: Oseltamivir/berry-extract

Latest Information Update: 22 Feb 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator HerbalScience Group
  • Developer HSRx Biopharmaceutical
  • Class Antivirals; Herbal medicines; Small molecules
  • Mechanism of Action Neuraminidase inhibitors; Virus attachment inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Influenza virus infections

Most Recent Events

  • 22 Feb 2022 Discontinued - Phase-II for Influenza virus infections (PO)
  • 05 Aug 2015 HSRx Biopharmaceutical in-licenses 8 proprietary pharmaceutical products from HerbalScience Group
  • 01 Nov 2014 Phase-II clinical trials in Influenza virus infections (PO)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top